A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19.

Diaby V, Almutairi RD, Chen Z, Moussa RK, Berthe A. A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19. Expert Rev Pharmacoecon Outcomes Res. 2021 Feb; 21(1):159-168.

View in: PubMed

subject areas

Adverse Drug Reaction Reporting Systems
Anti-Bacterial Agents
Antimalarials
Arrhythmias, Cardiac
Azithromycin
Drug Therapy, Combination
Electrocardiography
Humans
Long QT Syndrome
Torsades de Pointes
United States
United States Food and Drug Administration

authors with profiles

Vakaramoko Diaby

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support